PUBLISHER: The Business Research Company | PRODUCT CODE: 1713515
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713515
Artificial organs and bionic implants are sophisticated medical devices designed to either replace or enhance the function of damaged or missing biological organs and limbs. These technologies are intended to restore normal physiological functions or improve the quality of life for individuals suffering from severe injuries or organ failures.
The primary product categories in this field are artificial organs and artificial bionics. Artificial organs are engineered devices that take over the functions of natural organs within the body. This category includes both mechanical bionics and electronic bionics, which cater to various end users such as hospitals, ambulatory surgical centers, and other medical facilities.
The artificial organs and bionic implants market research report is one of a series of new reports from The Business Research Company that provides artificial organs and bionic implants market statistics, including artificial organs and bionic implants industry global market size, regional shares, competitors with artificial organs and bionic implants market share, detailed artificial organs and bionic implants market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organs and bionic implants industry. This artificial organs and bionic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artificial organs and bionic implants market size has grown strongly in recent years. It will grow from $45.02 billion in 2024 to $48.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to an increase in the elderly population, a rising incidence of organ failure, advances in minimally invasive and robotic surgery, a rise in demand for electronic bionic implants, and increased healthcare expenditure.
The artificial organs and bionic implants market size is expected to see strong growth in the next few years. It will grow to $66.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing incidences of conditions such as diabetes, cardiovascular diseases, and kidney failure; the prevalence of organ transplants; the rising number of individuals awaiting donors; several advantages of the product to surge; and the increasing number of transplants. Major trends in the forecast period include advancements in 3D bioprinting technology, the integration of nanotechnology, the development of smart implants, utilizing AI to design and optimize artificial organs, and the development of new biocompatible materials.
The increasing prevalence of organ transplants is expected to drive the growth of the artificial organs and bionic implants market. Organ transplants involve surgically implanting a healthy organ from a donor into a recipient whose organ is diseased, damaged, or non-functional. This rise in organ transplants is driven by growing incidences of chronic diseases and organ failures, along with advancements in medical technology and surgical techniques. Artificial organs and bionic implants play a crucial role in organ transplantation by providing temporary solutions, reducing wait times, improving patient outcomes, and offering alternatives when donor organs are not available. For instance, the United Network for Organ Sharing reported in January 2023 that 42,887 organ transplants were performed in the United States in 2022, representing a 3.7% increase from 2021. Therefore, the growing prevalence of organ transplants is contributing to the expansion of the artificial organs and bionic implants market.
Leading companies in this market are focusing on developing cutting-edge solutions such as brain implant technology systems to enhance cognitive function and address neurological disorders. These brain implant technology systems consist of devices that interact with the brain to monitor, stimulate, or modify neural activity for medical treatment, neuroprosthetics, or research purposes. For example, in May 2023, Neuralink Corp., a US-based neurotechnology company, received FDA approval to conduct its first human clinical trials for its brain implant technology. This technology aims to help individuals with severe paralysis by enabling them to communicate with and control external devices using only their thoughts. This approval marks a significant achievement for Neuralink, which had previously faced challenges, including a rejection due to safety concerns. The trial will assess the device's ability to interpret neural signals and transmit them via Bluetooth to control computers and mobile devices, potentially benefiting those with conditions such as amyotrophic lateral sclerosis (ALS).
In May 2022, LivaNova plc, a UK-based medical device manufacturer, acquired ALung Technologies Inc. for an undisclosed amount. This acquisition enables LivaNova to expand its respiratory device portfolio by integrating the Hemolung Respiratory Assist System and leveraging its infrastructure to accelerate global commercialization and address the need for effective CO2 removal therapies. ALung Technologies Inc., a US-based company, specializes in the design and manufacture of artificial organs and bionic implants.
Major companies operating in the artificial organs and bionic implants market are Medtronic plc, Asahi Kasei Medical Co. Ltd., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Terumo Medical Corp., Edwards Lifesciences Corporation, Ottobock SE and Co. KGaA, Cochlear Limited, Ossur hf., Thoratec Corporation, Berlin Heart GmbH, Jarvik Heart Inc., SynCardia Systems LLC, BiVACOR Inc., Gambro AB, Pixium Vision, ALVI Labs, WillowWood Global LLC, Nano Retina Inc., Organovo Holdings Inc.
North America was the largest region in the artificial organs and bionic implants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organs and bionic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial organs and bionic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial organs and bionic implants market consists of sales of cochlear implants, neural implants, artificial bladders, and bionic arms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Organs And Bionic Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial organs and bionic implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial organs and bionic implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial organs and bionic implants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.